Fibroblasts as key effectors of acupuncture in treatment of rheumatoid arthritis

This pioneering study reveals a previously unknown mechanism by which acupuncture relieves rheumatoid arthritis pain, focusing on the fundamental role of fibroblasts — connective tissue cells previously considered merely structural. The researchers used a murine model of arthritis induced by complete Freund's adjuvant (CFA) to investigate the effects of manual acupuncture at the ST-36 (Zusanli) point. The methodology included detailed histological analyses, molecular profiling by RT-qPCR and immunohistochemistry, in addition to an innovative approach of fibroblast-specific ablation using recombinant adeno-associated virus. The results demonstrated that acupuncture promotes significant improvement of thermal hyperalgesia and reduction of joint inflammation.

More importantly, the treatment induced robust molecular changes in the microenvironment of the acupoint, including increased expression of mechanosensitive proteins such as Piezo1, RhoA, and YAP1, in addition to components of the extracellular matrix such as collagen I, fibromodulin, and hyaluronic acid. The study also identified elevation of fibroblast activation markers, including FGF-2, FGF-7, FSP-1, CB2, and PCNA. To prove the causal role of fibroblasts, the researchers developed a cell-specific ablation system that demonstrated that the depletion of fibroblasts at the ST-36 point significantly attenuates the analgesic effects of acupuncture. Histological analysis after ablation revealed disorganization of collagen fibers, reduction in proteoglycan content, and decreased mast cell degranulation.

These findings suggest that fibroblasts function as primary mechanical sensors that translate the physical stimulation of acupuncture into biochemical cascades of tissue repair and pain modulation. The proposed mechanism involves the mechanical activation of fibroblasts through Piezo1 channels, leading to extracellular matrix remodeling and signaling via cannabinoid CB2 receptors. This discovery represents a paradigm shift from the traditional neurocentric model to a model that recognizes the stromal component as an active mediator of the therapeutic effects of acupuncture. The clinical implications are substantial, suggesting that fibroblast-targeted therapies could potentiate the effects of acupuncture.

The study also identifies potential biomarkers such as HAS2, HABP2, and FGF-2 that could predict treatment response. Limitations include the focus on acute inflammation and the short-term protocol, requiring validation in chronic pain models and prolonged treatments.